期刊文献+

洛美利嗪对大鼠脑微血管内皮细胞上P-糖蛋白活力的影响与P-gp及mdr1基因mRNA表达无关(英文) 被引量:4

Lomerizine inhibited the function of P-glycoprotein(P-gp) without decreasing the expression of mdr1 gene and P-gp in primarily cultured rat brain microvessel endothelial cells
下载PDF
导出
摘要 目的:研究洛美利嗪对原代培养的大鼠脑微血管内皮细胞(RBMECs)上P-糖蛋白(P-gp)功能和表达的影响。方法:使用流式细胞术分析洛美利嗪对P-gp底物-罗丹明123(rhodamine123,Rh123)在RBMECs中外排的影响,使用流式细胞术分析了洛美利嗪对RBMECs上P-gp表达的影响,应用RT-PCR技术分析了洛美利嗪对RBMECsmdr1基因mRNA水平表达的影响,还使用Transwell模型研究了洛美利嗪对Rh123通透RBMECs单层细胞转运的影响。结果:洛美利嗪通过抑制了RBMECs胞内Rh123的外排;洛美利嗪对P-gp功能的影响与RBMECs上P-gp及mdr1基因mRNA表达无关;在Transwell模型中,洛美利嗪还能显著增加Rh123跨RBMECs单层细胞膜的、经上室至下室的转运,并抑制相反方向的Rh123的转运。结论:洛美利嗪能显著地抑制RB-MECs上P-gp的活性,并对P-gp底物的跨细胞转运产生影响。 AIM: To study the effect of Lomerizine on the activity of P-glycorprotein (P-gp) in primary cultured rat brain microvessel endothelial cells (RBMECs). METHODS: Flow cytometry was used to study the efflux of rhodamine123 (Rh123) and expression of P-gp in RBMECs. RT-PCR was used to measure the expression in mRNA level of mdrl gene in RBMECs. Transwell model was used to detect the influence of Lomerizine on the transport of Rh123 through RBMECs monolayer. RESULTS: Lomerizine inhibited the efflux of Rh123 in RBMECs. No changes of P-gp and mdrl gene mRNA expression were detected in RBMECs after the treatment with 30μmol· L^-1 Lomerizine for 72 h. In the study of Transwell model, Lomerizine increased significantly the transport of Rh123 through RBMECs monolayer from upper compartments to lower compartments, and inhibited obviously the transport in reverse direction. CONCLUTION: The effect of Lomerizine on the activity of P-gp was mainly via its direct inhibitory effect on the function of P-gp in RBMECs and the transport of P-gp substrates in BBB may be affected by lomerizine.
出处 《中国临床药理学与治疗学》 CAS CSCD 2006年第1期45-50,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 P-糖蛋白 洛美利嗪 罗丹明123 大鼠脑微血管内皮细胞 流式细胞术 TRANSWELL P-glycoprotein Lomerizine rat brain microvessel endothelialcells flow cytometry transwell rhodamine123
  • 相关文献

参考文献7

  • 1Abbott NJ,Hughes CC,Revest PA,Greenwood J.Development and characterization of a rat brain capillary endothelial culture:towards an in vitro blood-brain barrier[J].J Cell Sci,1992;103:23-37
  • 2Ghetie MA,Ghetie V,Vitetta ES.Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells[J].Clin Cancer Res,1999;5:3920-7
  • 3Shabbits JA,Mayer LD.P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs[J].Mol Cancer Ther,2002;1:205-13
  • 4Regina A,Koman A,Piciotti M,El Hafny B,Center MS,Bergmann R,Couraud PO,Roux F.Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells[J].J of Neurochem,1998;71:705-15
  • 5Levin V.Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability[J].J Med Chem,1980;23:682-4
  • 6Schinkel AH,Smit JJM,Tellingen OV.Disruption of the mouse mdr1aP-Glycoprotein gene leads to a deficiency in the blood-brain barrier and to increasedsensitivity to drugs[J].Cell,1994;77:491-502
  • 7Shiraki N,Hamada A,Ohmura T,et al.Increase in doxorubicin cytotoxicity by inhibition of P-glycoprotein activity with Lomerizine[J].Biol Pharm Bull,2001;24:555-7

同被引文献39

  • 1魏志霞.川芎嗪对肝癌多药耐药株SMMC-7721/ADM的逆转作用[J].江苏医药,2005,31(5):371-372. 被引量:21
  • 2李振波,丘和明.活血化瘀法治疗恶性肿瘤的讨论[J].中国中西医结合杂志,1996,16(9):559-561. 被引量:37
  • 3刘晓磊,唐靖,宋娟,何娟,徐萍,彭文兴.川芎嗪对大鼠灌服环孢素A药代动力学的影响[J].药学学报,2006,41(9):882-887. 被引量:16
  • 4SUN J, HE Z G, CHENG G, et al. Muhidrug resistance p-glycoprotein: crucial significance in drug disposition and interaction [J]. Med Sci Monlt,2004,10( 1 ) :5-14.
  • 5WAGNER D. Intestinal drug efflux:formulation and food effects [J]. Adv Drug Deliv Rev,2001,50(Suppl 1 ) :13-31.
  • 6ZHOU S F, LIM L Y, CHOWBAY B. Herbal modulation of pglycoprotein[ J]. Drug Metab Rev,2004,36( 1 ) :57-104.
  • 7MENG Z, ZHANG H, ZHAO Y, et al. Transport behavior and efflux of Rgl in rat pulmonary epithelial cells[ J ]. Biomed Chrom- atogr,2007,21 (6) :635-641.
  • 8OFER M, WOLFFRAM S, KOGGEL A, et al. Modulation of drug transport by selected flavonoids: involvement of p-gp and OCT [ J ]. Eur J Pharm Sci,2005,25 ( 2-3 ) :263-271.
  • 9EFFERTH T, DAVEY M, OLBRICH A, et al. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRPl-overexpressing multidrug-resistant human CCRF-CEM leukemia cells[J]. Blood Cells Mol Dis,2002,28(2) :160-168.
  • 10CHEN J. Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caeo-2 model [ J ]. Cancer Chemother Pharmacol,2005, 55 (2) : 159-169.

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部